ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2021

Conference call and webcast on Tuesday, September 21, 2021 at 8:30am EDT / 2:30pm CET

ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today provided a business update and reported its financial results for the first half of 2021.